Bacillus Subtilis: A Probiotic Champion Against Harmful Bacteria

Bacillus subtilis: Probiotic Champion Against Harmful Bacteria

Most probiotics are known for simply “taking up space” in the gut and helping restore balance after antibiotics. Bacillus subtilis is different. This hardy, spore-forming probiotic doesn’t just survive the journey through your stomach—it brings a built-in defense system. What makes Bacillus subtilis unique is its ability to naturally produce a wide variety of protective compounds. Research shows many of these compounds have antimicrobial activity against a variety of microbes, helping support a healthier balance within the gut ecosystem.

Bacillus Subtilis Champion Defender Against Pathogens

A Probiotic With Built-In Defenses

Researchers have discovered that B. subtilis devotes a surprising amount of its genetic code—approximately 4–5%—to making more than 60 different antimicrobial substances. Laboratory studies show that these natural compounds, sometimes called “bacteriocins” or “lipopeptides,” can inhibit a variety of microbes such as Clostridium difficile, Helicobacter pylori, E. coli, and even fungal invaders, helping support a balanced ecosystem. By producing these natural defenses, B. subtilis helps protect your microbiome, making it one of the most powerful and versatile probiotic species studied today.

Natural Antibiotics Produced by Bacillus subtilis

Scientists group these natural defenses into three main categories:

subtilin, mersacidin

Lantibiotics

Disrupt bacterial cell walls. Especially effective against Gram-positive pathogens such as C. difficile and Staphylococcus aureus (including MRSA).

surfactin, iturins, fengycins

Lipopeptides

Damage microbial membranes and break down biofilms where pathogens hide. Active against fungi and biofilm-forming bacteria.

bacilysin, difficidin, amicoumacins

Other Small Molecules

Broad-spectrum antimicrobial activity. Suppress harmful gut bacteria like E. coli, Klebsiella, and Salmonella. Amicoumacin A also has anti-inflammatory effects, adding extra support for gut tissue.

Another Interesting B. subtilis Product: Nattokinase

B. subtilis produces more than antimicrobial compounds. It also produces enzymes such as nattokinase, a protein-degrading (proteolytic) enzyme produced at particularly high levels by the B. subtilis strains traditionally used to make the fermented food natto.

Nattokinase production occurs more broadly among B. subtilis strains, although the amount can vary considerably from strain to strain.

Nattokinase is best known for its fibrin-degrading activity. Its protein-degrading properties have also generated interest in its potential effects on microbial biofilms, although more research is needed to understand how important this activity may be in the gut.

Pathogens Targeted by These Natural Defenses

The natural compounds made by Bacillus subtilis have been shown in laboratory and experimental studies to inhibit a wide range of microorganisms, including:

Clostridium difficile (C. diff)

Lantibiotics and difficidin can inhibit growth and biofilms of C. difficile.

Helicobacter pylori (H. pylori)

Studies show suppression through amicoumacin A and other compounds, even against resistant strains.

Staphylococcus aureus (Staph) and MRSA

Lantibiotics target gram-positive bacteria like Staph.

E. coli, Klebsiella, and Enterobacteriaceae

Broad inhibition by bacilysin and difficidin.

Salmonella and Campylobacter

Reduced colonization in lab and animal models.

Fungal Pathogens

Iturins and fengycins damage fungal cell membranes and disrupt growth.

A Probiotic With a Pharmacy Inside

Bacillus subtilis stands apart from other probiotics. Instead of only competing for space in the gut, it actively produces natural compounds that fight harmful microbes, support the immune system, and help maintain a healthier balance of gut flora. This unique defense system makes B. subtilis one of the most promising probiotics for protecting and restoring gut health.

What the Research Shows

Below is a selection of published research on the antimicrobial actions of Bacillus subtilis and its natural compounds. These studies demonstrate its ability to inhibit harmful bacteria, suppress biofilms, and support healthy microbial balance:

Amicoumacin A

Production of amicoumacin A with strong activity against Helicobacter pylori (Suva et al., 2016; H. pylori inhibition study).

Gram-Positive Activity

Discovery of subtilin and mersacidin lantibiotics active against Gram-positive bacteria including C. difficile.

Biofilm Disruption

Research on surfactin, iturin, and fengycin showing biofilm disruption and antifungal effects.

E. coli Activity

Studies documenting B. subtilis suppression of E. coli, Klebsiella, and other gut pathogens.

Antibiotic-Associated Diarrhea (AAD)

Clinical trials showing B. subtilis probiotics reduce antibiotic-associated diarrhea and normalize gut flora.

Experience the Benefits of Bacillus subtilis

High Potency Bacillus subtilis

HU58 contains a potent, DNA-verified strain of Bacillus subtilis designed to survive digestion and support gut health. Learn more about single strain HU58 on our product page below.

HU58 is also inside MegaSporeBiotic probiotic blend.

HU58 Product Page

References

Suva MA, Sureja VP, Kheni DB. Novel insight on probiotic Bacillus subtilis: Mechanism of action and clinical applications. J Curr Res Sci Med. 2016;2(2):65-72. doi:10.4103/2455-3069.198381.
Bacillus subtilis antibiotics: structures, syntheses and specific functions Molecular Microbiology (2005) 56(4), 845–857 doi:10.1111/j.1365-2958.2005.04587.x
In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Pinchuk, I. V., P. Bressollier, B. Verneuil, B. Fenet, I. B. Sorokulova, F. Megraud, and M. C. Urdaci. 2001. Antimicrob. Agents Chemother. 45:3156-3161.
Pathogen elimination by probiotic Bacillus via signalling interference. P Piewngam et al. Nature DOI: 10.1038/s41586-018-0616-y (2018).
Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial. Piewngam P, Khongthong S, Roekngam N, Theapparat Y, Sunpaweravong S, Faroongsarng D, Otto M. Lancet Microbe. 2023 Feb;4(2):e75-e83. doi: 10.1016/S2666-5247(22)00322-6. Epub 2023 Jan 13. PMID: 36646104.
Inatsu Y, Nakamura N, Yuriko Y, Fushimi T, Watanasiritum L, Kawamoto S. Characterization of Bacillus subtilis strains in Thua nao, a traditional fermented soybean food in northern Thailand. Letters in Applied Microbiology. 2006;43(3):237–242. doi:10.1111/j.1472-765X.2006.01966.x.
Yokoyama T, Nakamura T, Kimijima M, Mandokoro K, Tokumaru M, Takatsuka A, Narisawa N, Kobayashi R, Takenaga F. Subtilisin NAT, a subtilisin-like serine protease present in fermented soybean “natto” extract, inhibits Streptococcus mutans biofilm formation. Food Science and Technology Research. 2021;27(3):537–542. doi:10.3136/fstr.27.537.

Health Disclaimer

This page is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement. See our full terms of use for details.